TRAIL   Click here for help

GtoPdb Ligand ID: 5065

Synonyms: Apo-2 ligand (Apo-2L)
Comment: TRAIL is a cytokine of the tumor necrosis factor (TNF) ligand family. TRAIL binds to several TNF family receptors, activating MAPK8/JNK, caspase 8, and caspase 3. Its interaction with death receptors on tumor cells triggers apoptosis. Binding to decoy receptors may neutralise TRAIL activity. Because TRAIL exhibits much stronger apoptotic activity than other TNF family members, kills tumor cells more effectively than normal cells, and presents less risk of inducing an inflammatory repsonse following systemic administration, use of TRAIL as an anti-cancer therapeutic has been widely examined. Huang et al. (2017) [2] describe the development and potent anti-tumor activity of a TRAIL fusion protein nanoparticle formulation in a xenograft model [1]. To date, no pharmaceutical agents targeting TRAIL or its receptors in cancer have been approved.
Species: Human
Click here for help
Natural/Endogenous Targets
Target
death receptor 4
death receptor 5
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
death receptor 5 Ligand is endogenous in the given species Hs Agonist Agonist 7.2 pKd - 3
pKd 7.2 (Kd 5.9x10-8 M) [3]
death receptor 4 Ligand is endogenous in the given species Hs None - - - -
Targets where the ligand is described in the comment field
Target Comment